Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study Barrero Hernández, Francisco Javier Mallada-Frechin, J Martínez-Ginés, ML Marzo, ME Meca-Lallana, V Izquierdo, G Ara, JR Oreja-Guevara, C Meca-Lallana, J Forero, L Sánchez-Vera, I Moreno, MJ 2024-09-04T07:57:19Z 2024-09-04T07:57:19Z 2020-04 journal article Barrero F, Mallada-Frechin J, Martínez-Ginés ML, Marzo ME, Meca-Lallana V, Izquierdo G, Ara JR, Oreja-Guevara C, Meca-Lallana J, Forero L, Sánchez-Vera I, Moreno MJ; in representation of the MS NEXT study investigators. Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study. PLoS One. 2020 Apr 2;15(4):e0230846. doi: 10.1371/journal.pone.0230846. PMID: 32240213; PMCID: PMC7117743. https://hdl.handle.net/10481/93891 10.1371/journal.pone.0230846. eng http://creativecommons.org/licenses/by-nc-nd/4.0/ open access Attribution-NonCommercial-NoDerivatives 4.0 Internacional PLOS